Investors

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
More>>
Featured Reports
2017 Annual Report on Form 10-K - PDF 2017 Annual Report on Form 10-K
Fact Sheet - PDF Fact Sheet
OSUR (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$15.46
Change (%) Stock is Down 0.06 (0.00%)
Volume291,542
Data as of 09/20/18 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
09/06/18OraSure Technologies to Present at the CL King 16th Annual Best Ideas Conference
BETHLEHEM, Pa., Sept. 06, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Stephen S. Tang, President and CEO, will speak to the investment community at the CL King 16th Annual Best Ideas Conference. The conference will be simultaneously webcast over the Internet.  Dr. Tang is scheduled to speak on September 13, 2018, at approximately 12:30 PM Eastern Time (9:30 AM Pacific Time)... 
Printer Friendly Version
08/08/18OraSure Announces 2018 Second Quarter Financial Results
BETHLEHEM, Pa., Aug. 08, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the three and six months ended June 30, 2018. Financial Highlights Consolidated net revenues for the second quarter of 2018 were $43.6 million, a 9% increase from the second quarter of 2017. Consolidated net product revenues were $38.8 million, representing a 1% dec... 
Printer Friendly Version
07/23/18OraSure Technologies, Inc. Appoints Vice President, Corporate Communications
BETHLEHEM, Pa., July 23, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostics and specimen collection devices, today announced that Jeanne Mell has been appointed as the Company’s new Vice President, Corporate Communications. Ms. Mell will join OraSure on August 13, 2018. Most recently, Ms. Mell served as Vice President Marketing Communications at the University City Science Center in Philadelphia, where she was responsible for corporate m... 
Printer Friendly Version
07/19/18OraSure Technologies Earnings Conference Call Invitation
2018 Second Quarter Earnings Conference Call Wednesday, August 8, 2018, 5:00 p.m. ET BETHLEHEM, Pa., July 19, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2018 second quarter financial results, 2018 third quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, August 8, 2018.  August 8, 2018 Schedule 4:00 p.m. ET 2018 second quarter financial resul... 
Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources



Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet